Creative Planning Red Hill Biopharma Ltd. Transaction History

Creative Planning

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.14 - $695.9 $2,352 - $11.7 Million	16,800 Added 24.85%	84,401 $11,000
Q2 2021 Aug 04, 2021	SELL	$5.98 - $7.51 $4.42 Million - $5.56 Million	-739,778 Reduced 91.63%	67,601 $465,000
Q1 2021 Apr 30, 2021	BUY	$6.98 - $11.29 $17,177 - $27,784	2,461 Added 0.31%	807,379 $5.91 Million
Q4 2020 Jan 29, 2021	BUY	$7.81 - $10.39 $37,652 - $50,090	4,821 Added 0.6%	804,918 $6.5 Million
Q3 2020 Nov 05, 2020	BUY	$6.34 - $10.83 $117,511 - $200,734	18,535 Added 2.37%	800,097 $8.18 Million
Q2 2020 Jul 23, 2020	BUY	$4.6 - $8.6 $1.67 Million - $3.13 Million	363,847 Added 87.1%	781,562 $5.24 Million
Q1 2020 May 05, 2020	BUY	$3.51 - $6.17 $111,972 - $196,829	31,901 Added 8.27%	417,715 $1.89 Million
Q4 2019 Jan 30, 2020	BUY	$5.76 - $7.35 $584,432 - $745,760	101,464 Added 35.68%	385,814 $2.34 Million
Q3 2019 Nov 01, 2019	BUY	$6.46 - $8.37 $6,460 - $8,370	1,000 Added 0.35%	284,350 $2 Million
Q4 2018 Feb 01, 2019	BUY	$5.18 - $9.35 $623,672 - $1.13 Million	120,400 Added 73.89%	283,350 $1.57 Million
Q3 2018 Oct 25, 2018	BUY	$6.0 - $11.35 $135,366 - $256,067	22,561 Added 16.07%	162,950 $1.44 Million
Q4 2017 Jan 17, 2018	BUY	$4.58 - $10.81 $642,981 - $1.52 Million	140,389	140,389 $722,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.